|
Opioid Overdose Risk and Prevention
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on opioid overdose – risks involved, prevention strategies & tips, and more to help you better understand how to combat opioid overdose and be better prepared in the event of an opioid overdose.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education ... |
|
|
How to Use Narcan (naloxone) Nasal Spray
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on Narcan (naloxone) nasal spray – how to administer the medication, proper technique, and more to help you better understand how to use Narcan (naloxone) nasal spray.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your com... |
|
|
Support Your Community with an Opioid eLearning Center Hosted by READINESS
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your community an intuitive and accessible eLearning center to support opioid education and awareness.
|
|
|
10-Night Peru CME AWAY™ Land Tour - Mood Disorders, ADD, COPD, Hypertension, VTE, Lyme Disease & High Altitude Illness
Lima, Peru ● Cusco, Peru ● Aguas Calientes, Peru ● Puno, Peru |
|
|
9-Night Kenya CME AWAY™ Land Tour - Cardiology, Diabetes, Mental Health, Obesity & Breast Cancer
Nairobi • Maasai Mara • Bogani Cottages & Tented Camp |
|
|
9-Night Kenya CME AWAY™ Land Tour - Neurology and Orthopedics: Brain vs Brawn
Nairobi • Maasai Mara • Bogani Cottages & Tented Camp |
|
|
11-Night Splendors of Egypt & the Nile CME AWAY™ - Thyroid Disorders, Diabetes, Dermatitis, Psoriasis and Pearls of Hair & Nail Disorders
Cairo • Luxor • Dendera • Kom • Ombo • Aswan • Edfu • Esna |
|
|
12-Night India’s Golden Triangle & The Sacred Ganges CME AWAY™ River Cruise
New Delhi • Agra • Jaipur • Kolkata • Kalna • Matiari • Murshidabad • Baranagar • Mayapur • Chandannagar • Kolkata |
|
|
13-Night Cook Islands, Society Islands, Tonga & Fiji CME AWAY™ Cruise - Updates in Endocrinology & Respirology
Papeete, Tahiti, Society Islands ● Moorea, Society Islands ● Taha'a, Society Islands ● Bora Bora, Society Islands ● Aitutaki, Cook Islands ● Vava’u, Tonga ● Savusavu, Vanua Levu, Fiji ● Suva, Viti Levu, Fiji ● Bequa Island, Fiji ● Lautoka, Viti Levu, Fiji |
|
|
14-Night Chile, Argentina & Uruguay CME AWAY™ Cruise - Emergency Medicine & Pediatrics Update
Buenos Aires, Argentina • Montevideo, Uruguay • Punta Del Este, Uruguay • Puerto Madryn, Argentina • Cape Horn, Chile • Ushuaia, Argentina • Punta Arenas, Chile • Puerto Montt, Chile • San Antonio, Chile |
|
|
12-Night Timeless Wonders of Vietnam, Cambodia & the Mekong CME AWAY™ - Cardiology, Respirology & Sleep Medicine
Ho Chi Minh City • My Tho • Tien Loi • Vinh Long • Sa Dec • Gieng Island • Hong Ngu • Phnom Penh • Angkor Ban • Wat Hanchey • Kampong Cham • Siem Reap |
|
|
14-Night South Africa CME AWAY™ Cruise - Medical Emergencies, Dental Disease & Its Relationship To Systemic Medical Conditions
Cape Town, South Africa • Walvis Bay, Namibia • Port Elizabeth, South Africa • Durban, South Africa • Maputo, Mozambique • Richards Bay, South Africa • Mossel Bay, South Africa |
|
|
7-Night Costa Mujeres CME AWAY Resort - Comprehensive Overview of Obesity Pathophysiology, Co-Morbidities, Non-Pharmacological & Pharmacological Treatment Options
Grand Palladium Costa Mujeres & TRS Coral, Costa Mujeres, Mexico |
|
|
7-Night Costa Mujeres CME AWAY Resort - Physician Empowerment: Physician Wellness, Resilience, & Practice Management
Grand Palladium Costa Mujeres & TRS Coral, Costa Mujeres, Mexico |
|
|
8-Night Panama CME AWAY Land Tour - Joint Disease and Replacement, MSK Injections, Rehabilitation, Dementia & Geriatrics
Panama City • Anton Valley • Chitre • Playa Bonita |
|
|
7-Night St. Lucia CME AWAY Resort - Dermatology & Aesthetic Medicine: Recent Advancements & Exciting Developments
Sandals Grande St. Lucian, Pigeon Island Gros Islet, St. Lucia |
|
|
7-Night Iceland CME Land Tour - Pain Management Across the Continuum: From Prevention to Palliation: Movement, Motivation, Mindfulness, Medication
Reykjavík, Iceland • Vik, Iceland |
|
|
8-Night Ireland CME Land Tour - Addictions, Fibromyalgia, Medical Cannabis & Sleep and Mood Disorders
Dublin, Ireland • Castlemartyr, Ireland • Killarney, Ireland • Dromoland Castle, Ireland • Shannon, Ireland |
|
|
6-Night Newfoundland CME Land Tour - Optimizing Functional Outcomes & Reducing Disability: A Biopsychosocial Approach to Chronic Pain
St. John’s, Newfoundland, Canada |
|
|
7-Night Tuscany CME AWAY™ Land Tour - Integrative Pain Management, Diabetes, Atrial Fibrillation & Hypertension
Tuscany, Italy |
|
|
Dr. Sarah Danial & Dr. Nasim Huq
Fort Lauderdale, Florida • San Juan, Puerto Rico • Charlotte Amalie, St. Thomas • Basseterre, St. Kitt’s & Nevis |
|
|
15-Night South & Central America Via the Panama Canal CME AWAY™ Cruise - State of the Art Management of Pain, Wellness & Practical Mindfulness
Lima (Callao), Peru • Salaverry, Peru Manta, Ecuador • Fuerte Amador (Panama City), Panama • Panama Canal Transit • Puerto Limón, Costa • Roatan Island, Honduras • Santo Tomas, Guatemala • Belize City, Belize • Cozumel Quintana Roo, Mexico • Fort Lauderdale (Florida), USA |
|
|
14-Night Vietnam & Thailand CME AWAY™ Cruise - Updates in Cardiology & Rheumatic Diseases
Hong Kong, China ● Hanoi (Ha Long Bay), Vietnam ● Hue/Danang (Chan May), Vietnam ● Ho Chi Minh (phu My), Vietnam ● Bangkok, Thailand ● Singapore |
|
|
9-Night Rhine & Moselle CME River Cruise - Updates on Urology & Psychiatry
Frankfurt, Germany • Cochem, Germany • Trier, Germany • Bernkastel, Germany • Rüdesheim, Germany • Speyer, Germany • Strasbourg, Germany |
|
|
7-Night Alaska CME AWAY™ Cruise - Updates in Emergency Medicine, Transgender Health & Sexual Medicine
Seattle, Washington ● Juneau, Alaska ● Skagway, Alaska ● Endicott Arms & Dawes Glacier, Alaska ● Victoria, British Columbia |
|
|
Optimizing Patient Outcomes in Diabetic Retinopathy
Target Audience
Content and educational strategies have been designed to facilitate behavior change in ophthalmologists, primary care physicians, residents and fellows, physician assistants, nurse practitioners, optomistrists, and all health care providers (HCPs) who care for patients at risk for diabetes and associated retinal disease.
Learning Objectives
Upon completion of this activity, participants should be able to:
Identify and compare current treatment pathways for diabetic ... |
|
|
PES Yachting the Seychelles Islands: Hot Topics in Medical, Dental & Public Health Issues
Join PES & earn 12 CME/CE credits while sailing for 7 nights through the topaz waters of the Indian Ocean to the tropical paradise of the Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await! Take in this exotic part of the world aboard the 62-guest, all-inclusive, all-suite luxury yacht Crystal Esprit, and be pampered with butler service in every category.
Hot Topics in Medical, Dental & Public Health Issues
CME/CE Lecture Seminars for M... |
|
|
Zooming in on the Education and Empowerment of Patients in AMD Care
FDA-approved agents that target vascular endothelial growth factor (VEGF) constitute important elements of optimal management of AMD. Prior authorization (PA) requirements limit patient access to these therapies. Navigating the PA process can be frustrating for patients, and may result in treatment abandonment leading to suboptimal outcomes. Hence, there is a need for patients to become advocates of their treatment choice.
The final module of this CME Outfitters Snack series describes step ... |
|
|
Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication
The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening disea... |
|
|
Keeping the Patient in the Center in AMD Care
Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step the... |
|
|
Photodynamic Therapy Then & Now: Current Concepts for Real-World Use
Verteporfin for photodynamic therapy (PDT) has been approved for decades as a treatment for retinal disorders. Eye care professionals need to understand all the real-world clinical scenarios in which the use of PDT alone or in combination with anti-VEGF therapy can be a more efficacious treatment option than anti-VEGF monotherapy.
View this engaging webinar to gain insight into PDT treatment options as demonstrated with case examples presented by leading retina specialists. |
|
|
Using Photodynamic Therapy in 2019: Current Concepts for Real-World Use
Verteporfin for photodynamic therapy (PDT) has been approved for decades as a treatment for retinal disorders. Eye care professionals need to understand all the real-world clinical scenarios in which the use of PDT alone or in combination with anti-vascular endothelial growth factor (VEGF) therapy can be a more efficacious treatment option than anti-VEGF monotherapy. |
|
|
Glaucoma Treatment: Tackling Real-World Cases
Topical pharmacologic therapy is the primary treatment for patients with primary open-angle glaucoma and ocular hypertension. However, in many patients multiple medications and different classes of drugs are often needed before there is adequate IOP control. After nearly a decade without new pharmacologic treatments, two new formulations were approved in late 2017. View this case-based webinar to learn how the latest treatments are helping to manage glaucoma. |
|
|
Case Studies: Advances in Glaucoma Therapy
This webcast highlights through a series of case studies the current advances in glaucoma therapy. Upon completion of this activity, participants will be better able to:
•Explain how novel therapeutics differ in their methods of action from other topical medications.
•Evaluate the safety and efficacy of latanoprostene bunod for ocular hypertension and primary open-angle glaucoma.
•Describe how a healthy eye manages intraocular pressure in contrast with an unhealthy eye. |
|
|
Current and Future Glaucoma Management: An Update on Existing Options and the Therapeutic Pipeline
Topical pharmacologic therapy is the mainstay primary treatment for patients with primary open-angle glaucoma (POAG) and ocular hypertension. Unfortunately, many patients need to be on multiple medications and different classes of drugs before there is adequate intraocular pressure (IOP) control. And for some patients, visual field loss will progress despite adequate IOP control. Until recently, no new topical pharmacologic treatments had been approved in the United States for more than a deca... |
|
|
Chronic Eye Diseases: Exploring Sustained-Release Treatments
This webcast highlights chronic eye disease and sustained release treatments. |
|
|
Sustained-Release Devices for the Treatment of Chronic Eye Diseases
Traditional topical drug delivery for the treatment of ocular diseases has a number of challenges including compliance; tearing and blinking, which results in medication spillage and drug dilution; tear film turnover; and inadequate absorption. In addition, medication noncompliance and loss to follow-up are additional common problems, especially for patients with with chronic diseases like age-related macular degeneration, diabetic macular edema and glaucoma.
To combat these challenges to t... |
|
|
Novel Glaucoma Therapies: Tailoring Treatment for Each Patient
This webinar focusing on medical glaucoma will provide a thorough review of the latest trabecular outflow medications, including their mechanisms of action and safety and efficacy profiles. In addition, cases that highlight which treatments are best suited for specific patients will be presented. |
|
|
Disease Modifying Glaucoma Treatments and Novel Therapies
Two new drugs in novel classes were approved recently for IOP reduction in eyes with ocular hypertension or open-angle glaucoma. View this webinar, hosted by two glaucoma experts, to learn more about these new treatments, plus therapeutics pending approval by the FDA. A case series is also included in this presentation. This webcast with two thought leaders discusses these novel classes. |
|
|
Updates in Dry Eye Disease: Diagnosing and Treating Patients with Ocular Surface Disease
ACTIVITY DESCRIPTION
Nearly 33% of patients in eye care clinics present with complaints about dry eye signs and symptoms. Clinicians remain challenged with both the diagnosis and best treatment options for dry eye disease (DED) because, to date, multiple causes of the disorder have been identified. Yet the proportion of US adults who reported having symptoms of DED seemed to plateau from 2015-2018, with about 41% noting occasional DED and 12% noting frequent DED. Extrapolating those figures t... |
|
|
Visually Induced Trigeminal Dysphoria: A Potential Leading Source of Headaches, Eyestrain, and Dry Eye Sensation
Trigeminal dysphoria is a term that describes a variety of symptoms including headaches, eyestrain, dry eye sensation, neck, and shoulder pain. New research suggests that computer vision syndrome, also called digital eye strain, is a form of visually induced trigeminal dysphoria. Clinicians who treat patients with these symptoms must be aware and understand why patients with trigeminal dysphoria are symptomatic and how to treat it. This journal supplement addresses these topics. |
|
|
Then, Now, and Tomorrow: Evolving the Management of Diabetic Retinopathy and the Role of the Optometrist
Diabetic retinopathy (DR) is the most common ocular complication of diabetes, responsible for more than 10,000 new cases of blindness yearly in the United States. This activity focuses on information for optometrists, as their role is crucial in educating patients with diabetes about the potential ocular complications of their systemic disorder and the benefits of diabetic eye exams and early treatment. |
|
|
DIABETIC RETINOPATHY: INCREASING DISEASE PREVALENCE
This webcast for Optometrists presents an over view of the prevelance of diabetic retinopathy in patients. |
|
|
EASTERN CARIBBEAN ISLANDS ON CRYSTAL: Medical & Dental Symposium at Sea
EASTERN CARIBBEAN ISLANDS ON CRYSTAL: Medical & Dental Symposium at Sea
Roundtrip Miami on Crystal Serenity
November 21 – December 2, 2020
Spend Thanksgiving with PES & earn 14 CME/CE credits while cruising the idyllic isles of the Eastern Caribbean for 11 nights in all-inclusive luxury! Rejuvenate and indulge while exploring the white sands and crystalline waters of a tropical paradise aboard the luxurious, all-inclusive, 980-guest Crystal Serenity.
Medical & Dental Symposium at Sea... |
|
|
YACHTING THE SEYCHELLES ISLANDS ON CRYSTAL ESPRIT: Hot Topics in Medical, Dental & Public Health Issues
Join PES & earn 12 CME/CE credits while sailing for 7 nights through the topaz waters of the Indian Ocean to the tropical paradise of the Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await! Take in this exotic part of the world aboard the 62-guest, all-inclusive, all-suite luxury yacht Crystal Esprit, and be pampered with butler service in every category.
Hot Topics in Medical, Dental & Public Health Issues
CME/CE Lecture Seminars for Me... |
|
|
SOUTHERN FRANCE RIVER CRUISE: Joint Medical/Dental Symposium Confronting Healthcare Needs
Joint Medical/Dental Symposium Confronting Healthcare Needs
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This Seminar is planned for 12 Continuing Education Credit Hours
CME/CE Professional Seminar Fee: $695
Seminar Attendance Fee: $450
CME/CE credits, Certificates of Completion and possible tax deductible guidelines will be provided for registered Professional Seminar attendees Certificates of Attendance will be provided for ALL registere... |
|
|
New Treatments for Open-Angle Glaucoma and Ocular Hypertension: An Update on New Therapeutic Options
CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a roundtable discussion that occurred on June 27, 2018.
ACTIVITY DESCRIPTION
Topical pharmacologic therapy is the mainstay primary treatment for patients with primary open-angle glaucoma (POAG) and ocular hypertension. Unfortunately, many patients need to be on multiple medications and different classes of drugs before there is adequate IOP control. And for some patients, visua... |
|
|
Case Presentations in Medical Glaucoma: A Review of Therapeutic Advances
CONTENT SOURCE
This continuing medical education (CME)/continuing education (CE) activity captures content from a roundtable discussion that occurred on October 17, 2018.
ACTIVITY DESCRIPTION
Glaucoma is a leading cause of preventable blindness in the United States, and at least 3 million Americans have a form of this chronic disease. Somewhat asymptomatic, patients may lose more than 40% of their optic nerve fibers before noticing a loss of peripheral vision and seeking medical intervent... |
|
|
Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 2
It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious.
The target audience for this CE Activity is Optometrists.
Learning Objectives
This educational activi... |
|
|
Treating Bipolar Disorder
This CE test is based on the book "Treating Bipolar Disorder" (2005, 212 pages). This innovative manual presents a powerful approach for helping people manage bipolar illness and protect against the recurrence of manic or depressive episodes. Interpersonal and social rhythm therapy focuses on stabilizing moods by improving medication adherence, building coping skills and relationship satisfaction, and shoring up the regularity of daily rhythms or routines. Each phase of this flexible, evidence... |
|